Transcatheter tricuspid interventions are performed too late: pros and cons

EuroIntervention 2023;19:717-719. DOI: 10.4244/EIJ-E-23-00041

Marianna Adamo
Marianna Adamo1, MD; Crina Ioana Radulescu1,2, MD; Shahrukh N. Bakar3, MD, FRCPC; Neil P. Fam3, MD, MSc, FRCPC
1. ASST Spedali Civili and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy; 2. University of Medicine Carol Davila, Bucharest, Romania; 3. Structural Heart Program, St. Michael’s Hospital, Toronto, ON, Canada
The rapid evolution of cardiovascular procedures has brought transcatheter tricuspid valve interventions (TTVI) to the forefront of contemporary practice. Early diagnosis of tricuspid regurgitation is difficult because of the subclinical course of the early phases, and patients are often referred to heart valve centres in the advanced stages.Timely TTVI might improve patient outcomes, prevent further right ventricular deterioration, and reduce the burden on healthcare systems, with such benefits being questionable in end-stage patients. On the other hand, the risks and potential complications associated with TTVI, coupled with the lack of long-term data, may warrant a more conservative approach. Whether ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Transcatheter mitral valve implantation for native valve disease

Latest news